SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA ARTICLE H impact

Astrazeneca, Bristol Myers Squibb Discuss Potential Merger

Astrazeneca and Bristol Myers Squibb in talks for potential combination

AZNBMY

AZN BMY Astrazeneca (AZN) and Bristol Myers Squibb (BMY) have held preliminary discussions about a potential combination that would create one of the world's largest Pharmaceutical companies, according to a report by the Financial Times. Astrazeneca (AZN) is valued at about £196B ($264B), while Bristol Myers Squibb (BMY) has a market capitalization of roughly $133B Link To Story from Reuters.com

Related stories